Compounds > miltefosine

miltefosine and atovaquone

miltefosine has been researched along with atovaquone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Brun, R; Dong, Y; Hemphill, A; Kaiser, M; Matile, H; Nehrbass-Stuedli, A; Vennerstrom, JL; Wang, X; Wittlin, S1
Brun, R; Carballeira, NM; Herman, R; Kappe, SH; Lauinger, IL; Perozzo, R; Sanabria, D; Tarun, A; Tasdemir, D; Zloh, M1
Azas, N; Cantelli, C; Casanova, M; Castera-Ducros, C; Cohen, A; Crozet, MD; Hutter, S; Laget, M; Paloque, L; Rathelot, P; Remusat, V; Tanguy, F; Vanelle, P; Verhaeghe, P1
Azas, N; Basmaciyan, L; Belle Mbou, V; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, É; Casanova, M; Castera-Ducros, C; Cohen, A; Courtioux, B; Fairlamb, AH; Fersing, C; Hutter, S; Laget, M; Milne, R; Pedron, J; Piednoel, M; Primas, N; Rathelot, P; Since, M; Sournia-Saquet, A; Valentin, A; Vanelle, P; Verhaeghe, P; Wyllie, S1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

5 other study(ies) available for miltefosine and atovaquone

ArticleYear
Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Animals; Antimalarials; Artemisinins; Eukaryota; Heterocyclic Compounds, 1-Ring; Iron; Parasitic Sensitivity Tests; Peroxides; Plasmodium falciparum; Sesquiterpenes; Spiro Compounds

2007
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
    Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21

    Topics: Alkynes; Antimalarials; Binding Sites; Cell Line, Tumor; Computer Simulation; Erythrocytes; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Kinetics; Liver; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins

2010
Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
    Bioorganic & medicinal chemistry, 2013, Nov-15, Volume: 21, Issue:22

    Topics: Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Imidazoles; Leishmania donovani; Mice; Pyridines; Structure-Activity Relationship

2013
Nongenotoxic 3-Nitroimidazo[1,2-
    ACS medicinal chemistry letters, 2019, Jan-10, Volume: 10, Issue:1

    Topics:

2019
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023